iProcess Global Research

iProcess Global Research

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

iProcess Global Research is a privately held, revenue-generating services company founded in 2008 and headquartered in San Diego, California. It has established itself as a key enabler in the life sciences research supply chain by providing access to a vast global inventory of clinically annotated biospecimens and managing complex, customized collection projects. The company differentiates itself through its extensive international network, regulatory compliance expertise, and the AxisOne digital platform, which aims to streamline laboratory collaboration and research execution for its clients.

Drug DeliverySmall Molecules

Technology Platform

AxisOne: An AI-powered, global R&D platform connecting researchers with a network of qualified laboratories for end-to-end scientific services, including molecular biology, genomics, proteomics, and biomarker discovery.

Opportunities

The growing demand for diverse, clinically annotated biospecimens in personalized medicine and global clinical trials presents a major opportunity.
The AxisOne platform allows iProcess to expand from a sample supplier to an essential end-to-end R&D partner, capturing more value from the research workflow.

Risk Factors

Key risks include operational failures in ethical sourcing or cold-chain logistics, intense competition in the fragmented biospecimen market, and the execution risk associated with scaling and gaining adoption for its new AxisOne digital platform.

Competitive Landscape

iProcess competes with large, full-service Contract Research Organizations (CROs), specialized global biorepositories, and regional biospecimen suppliers. Its differentiation lies in its extensive global collection network, compliance focus, and the integrated AxisOne digital platform for laboratory services.